- Category
- Micro (2021-22)
- Udyam number
- UDYAM-AP-13-0009936

Souris Pharmaceuticals Private Limited
About Souris Pharmaceuticals Private Limited
Data last updated:
Souris Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 29 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2021PTC156074.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Srinivasulu Daramavarapu and Gopireddy Roja.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 11( 407/52) 28th C Cross 11th Main Road Jayanagar 4th Block, Bangalore, Karnataka, India – 560011.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.06 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹22,003 (net margin 1.8%) and EBITDA of ₹1.48 Lakh (EBITDA margin 12.2%).
Souris Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-13-0009936).
Company details
Recognitions & Rankings of Souris Pharmaceuticals
Contact details
Souris Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo 11( 407/52) 28th C Cross 11th Main Road Jayanagar 4th Block, Bangalore, Karnataka, India – 560011
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Souris Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Souris Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Souris Pharmaceuticals Private Limited, buy the company report.
Financials of Souris Pharmaceuticals Private Limited
FY 2025 filings availableSouris Pharmaceuticals Private Limited reported revenue of ₹12.06 Lakh (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.48 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹22,003 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 12.2% | |||
| Net Profit Margin | 1.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Souris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Souris Pharmaceuticals Private Limited
Souris Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasulu Daramavarapu | Director | 29 Dec 2021 | 4 Years 10 Months | Current |
| Gopireddy Roja | Director | 29 Dec 2021 | 4 Years 10 Months | Current |
Peer comparison
Souris Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Souris Pharmaceuticals Private Limitedthis company | ₹12.06 Lakh (FY 2025) | ₹22,003 | 1.8% | -7.0% | Bangalore, Karnataka, India | |
| Zeinac Pharmaceuticals Private Limited | ₹12.05 Lakh (FY 2024) | 47.0% | Bareilly, Uttar Pradesh, India | |||
| Klyrich Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2025) | -18.0% | Lucknow, Uttar Pradesh, India | |||
| Sternum Pharmaceuticals Private Limited | ₹11.99 Lakh (FY 2023) | Ayodhya, Uttar Pradesh, India | ||||
| Singulans Pharmaceuticals Private Limited | ₹11.97 Lakh (FY 2024) | 4428.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Souris Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Souris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Souris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Souris Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Souris Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Gopireddy Roja was appointed as Director on 29 Dec 2021.
Frequently asked questions
Souris Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 29 December 2021 (5+ years old) and is registered under CIN U51909KA2021PTC156074.
Souris Pharmaceuticals has 2 current directors:
- Srinivasulu Daramavarapu - Director
- Gopireddy Roja - Director
The latest financial statements of Souris Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Souris Pharmaceuticals is U51909KA2021PTC156074. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Souris Pharmaceuticals was incorporated on 29 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Souris Pharmaceuticals by revenue are Zeinac Pharmaceuticals Private Limited, Klyrich Pharmaceuticals Private Limited, Sternum Pharmaceuticals Private Limited, Singulans Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gopireddy Roja was appointed as Director on 29 Dec 2021. Srinivasulu Daramavarapu was appointed as Director on 29 Dec 2021.
Yes, Souris Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-AP-13-0009936).
The registered office of Souris Pharmaceuticals is at No 11 40752 28th C Cross 11th Main Road Jayanagar 4th Block, Bangalore, Karnataka, India – 560011.
Souris Pharmaceuticals operates in the trading industry, in the specialty segment.
Souris Pharmaceuticals can be reached at its registered office: No 11 40752 28th C Cross 11th Main Road Jayanagar 4th Block, Bangalore, Karnataka, India – 560011.

